Videos

The CEO of the Digital Therapeutics Alliance explains why the group held its annual summit in Washington, D.C., discusses how it works with Congress on legislation around reimbursement – and describes just what a digital therapeutic is, exactly.  

Healthcare organizations should assess their security risks and be ready to defend against the types of cybercriminals that have recently impacted the industry, says Dave Bailey, VP, Consulting Services, at Clearwater Security.  

KP director of regional telemedicine and mobility Dr. Dennis Truong describes how the health system is using DTx to improve the care experience for both its patients and providers.  

Dr. Alan Forster, director of innovation, transformation and clinical performance at McGill University Health Centre, discusses data-driven insights to spot gaps in care and improve the evaluation of goals.  

The goal is to move digital therapeutics forward by ensuring validation and accreditation in healthcare, say Scott Stuewe, president and CEO of DirectTrust, and Andy Molnar, CEO of the Digital Therapeutics Alliance.  

Generative AI and large language models sometimes give inaccurate answers, says Dr. Calum Yacoubian, director of NLP healthcare strategy at IQVIA. He describes techniques that can improve algorithms' accuracy.  

Kyruus Health is a nationwide platform than aims to boost access for its 90 million members by using specific matching techniques and partnering with 120 health systems and 100 health plan brands. Kyruus president Paul Merrild explains.  

There are big differences between hospital-at-home and SNF-at-home care. Robert Latz, CIO of Trinity Rehabilitation Services, talks about some of the challenges of determining which is most appropriate for discharged patients.  

Holograms and extended reality have unique roles in patient engagement and education. Cole Wiser, executive creative director at the Virtual Wild, and Srini Iyer, SVP at Leidos, explain.  

Oscar Alleyne, managing director of the public health division, discusses the value of public and private partnerships and describes what its federally funded research and development centers do to help organizations plan for the next pandemic.